ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,386 | -27.1% | 214,557 | -14.9% | 0.01% | -31.2% |
| Q1 2023 | $1,902 | +4.1% | 252,192 | +39.8% | 0.02% | -40.7% |
| Q4 2022 | $1,827 | -99.9% | 180,350 | +3.2% | 0.03% | +17.4% |
| Q3 2022 | $1,728,000 | -38.2% | 174,750 | -33.4% | 0.02% | -32.4% |
| Q2 2022 | $2,796,000 | +122.6% | 262,503 | +103.7% | 0.03% | +112.5% |
| Q1 2022 | $1,256,000 | +6.1% | 128,851 | +55.6% | 0.02% | +33.3% |
| Q4 2021 | $1,184,000 | +79.7% | 82,825 | +176.3% | 0.01% | +71.4% |
| Q2 2021 | $659,000 | +109.9% | 29,972 | +224.3% | 0.01% | +40.0% |
| Q1 2021 | $314,000 | -73.0% | 9,243 | -68.0% | 0.01% | -54.5% |
| Q4 2020 | $1,161,000 | – | 28,850 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |